文献速递肾小球疾病慢性肾脏病

女性X连锁Alport综合征的自然病史与基因型-表型关联

Natural History and Genotype-Phenotype Correlation in Female X-Linked Alport Syndrome.
PubMed 文献 · Kidney Int Rep · 2017-05-04

INTRODUCTION: X-linked Alport syndrome (XLAS) is a hereditary disease characterized by progressive nephritis, hearing loss, and ocular abnormalities.…

要点

  • 女性XLAS患者蛋白尿常见,中位起病年龄7.0岁
  • 部分女性患者可进展至ESRD,中位肾脏生存年龄65.0岁
  • 基因型不能预测女性XLAS疾病严重程度

核心结论

  • 女性XLAS患者表型可能较重,但基因型无助于预测疾病严重程度。

研究设计与样本

  • 回顾性分析日本179个家系中275例基因确诊的女性XLAS患者及61例受累女性家属。
  • 纳入2006-2015年因病理或家族史疑诊Alport综合征并转诊进行基因诊断的女性。

主要发现

  • 175例基因确诊患者(72.6%)检出蛋白尿,中位起病年龄7.0岁。
  • 未观察到明显的基因型-表型关联;对重症患者行足细胞相关基因靶向测序,除1例COL4A3变异外未发现明显修饰基因变异。

临床怎么用

  • 临床医生需密切关注女性XLAS患者的临床病程并给予适当治疗。
  • 不应仅依据基因型判断女性XLAS的疾病严重程度。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: X-linked Alport syndrome (XLAS) is a hereditary disease characterized by progressive nephritis, hearing loss, and ocular abnormalities. Affected male patients usually progress to end-stage renal disease in early or middle adulthood, and disease severity is strongly correlated with genotype. However, the clinical course in female patients has rarely been reported. METHODS: We conducted a retrospective analysis of females with genetically proven XLAS (n = 275) and their affected female family members (n = 61) from 179 Japanese families. Patients suspected to have Alport syndrome from pathologic findings or a family history who were referred from anywhere in Japan for genetic diagnosis between 2006-2015 were included in this study. Clinical and laboratory data were collected from medical records at the time of registration for genetic analysis. RESULTS: Proteinuria was detected in 175 genetically proven patients (72.6%), and the median age for developing proteinuria was 7.0 years. Fifty-two of 336 patients developed end-stage renal disease with a median renal survival age of 65.0 years. No obvious genotype-phenotype correlation was observed. Additionally, targeted sequencing for podocyte-related genes in patients with severe phenotypes revealed no obvious variants considered to be modifier genes except for 1 patient with a COL4A3 gene variant. DISCUSSION: This study revealed that phenotypes in female XLAS patients may be severe, but genotype does not help to predict the disease severity. Clinicians must therefore pay careful attention to the clinical course and appropriate treatment in females with XLAS.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Yamamura T, Nozu K, Fu XJ, et al. Natural History and Genotype-Phenotype Correlation in Female X-Linked Alport Syndrome. Kidney Int Rep. 2017. PMID: 29270492. doi:10.1016/j.ekir.2017.04.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。